Advertisement

Citation tools

Byrd, John C. et al "Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib." Blood 125.16 (2015): 2497-2506. Web. 23 Oct. 2017.